Literature DB >> 8526974

Regional cortical anatomy and clozapine response in refractory schizophrenia.

W G Honer1, G N Smith, J S Lapointe, G W MacEwan, L Kopala, S Altman.   

Abstract

Regional measures of cortical sulcal and ventricular enlargement on computed tomography scan were studied in a clinical sample of patients treated with clozapine. Cortical sulci were significantly enlarged in clozapine nonresponders compared to responders. The Clinical Global Impressions score at discharge was related to the size of the posterior frontal and lateral temporal sulci, with large sulci predicting a poorer response to clozapine treatment.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8526974     DOI： 10.1016/0893-133X(95)00017-8

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


  10 in total

Review 1.  Predictors and markers of clozapine response.

Authors:  Carmen Chung; Gary Remington
Journal:  Psychopharmacology (Berl)       Date:  2005-02-17       Impact factor: 4.530

Review 2.  Factors associated with response to clozapine in schizophrenia: a review.

Authors:  Takefumi Suzuki; Hiroyuki Uchida; Koichiro Watanabe; Haruo Kashima
Journal:  Psychopharmacol Bull       Date:  2011

3.  A comprehensive method of assessing routine CT scans in schizophrenia.

Authors:  G N Smith; S W Flynn; L C Kopala; A S Bassett; J S Lapointe; P Falkai; W G Honer
Journal:  Acta Psychiatr Scand       Date:  1997-11       Impact factor: 6.392

4.  Impact cérébral structurel et fonctionnel de la Clozapine chez les patients souffrant de schizophrénie : revue systématique des études longitudinales en neuroimagerie.

Authors:  Anaïs Vandevelde; Lucie Métivier; Sonia Dollfus
Journal:  Can J Psychiatry       Date:  2020-11-02       Impact factor: 4.356

Review 5.  Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research.

Authors:  Paola Dazzan; Celso Arango; Wolfgang Fleischacker; Silvana Galderisi; Birte Glenthøj; Stephan Leucht; Andreas Meyer-Lindenberg; Rene Kahn; Dan Rujescu; Iris Sommer; Inge Winter; Philip McGuire
Journal:  Schizophr Bull       Date:  2015-03-23       Impact factor: 7.348

6.  Extensive gray matter volume reduction in treatment-resistant schizophrenia.

Authors:  Valerie M Anderson; Meghan E Goldstein; Robert R Kydd; Bruce R Russell
Journal:  Int J Neuropsychopharmacol       Date:  2015-02-25       Impact factor: 5.176

7.  Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia.

Authors:  Mario Quarantelli; Olga Palladino; Anna Prinster; Vittorio Schiavone; Barbara Carotenuto; Arturo Brunetti; Angela Marsili; Margherita Casiello; Giovanni Muscettola; Marco Salvatore; Andrea de Bartolomeis
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411

Review 8.  Neuroimaging biomarkers to predict treatment response in schizophrenia: the end of 30 years of solitude?

Authors:  Paola Dazzan
Journal:  Dialogues Clin Neurosci       Date:  2014-12       Impact factor: 5.986

9.  Biological Predictors of Clozapine Response: A Systematic Review.

Authors:  Ruta Samanaite; Amy Gillespie; Kyra-Verena Sendt; Grant McQueen; James H MacCabe; Alice Egerton
Journal:  Front Psychiatry       Date:  2018-07-26       Impact factor: 4.157

Review 10.  Brain-imaging studies of treatment-resistant schizophrenia: a systematic review.

Authors:  Elias Mouchlianitis; Robert McCutcheon; Oliver D Howes
Journal:  Lancet Psychiatry       Date:  2016-03-04       Impact factor: 27.083
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.